UA115168U - METHOD OF APPLICATION OF BONE MATRIX - Google Patents

METHOD OF APPLICATION OF BONE MATRIX

Info

Publication number
UA115168U
UA115168U UAU201609191U UAU201609191U UA115168U UA 115168 U UA115168 U UA 115168U UA U201609191 U UAU201609191 U UA U201609191U UA U201609191 U UAU201609191 U UA U201609191U UA 115168 U UA115168 U UA 115168U
Authority
UA
Ukraine
Prior art keywords
cells
buffer
rpm
treated
washed
Prior art date
Application number
UAU201609191U
Other languages
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAU201609191U priority Critical patent/UA115168U/en
Publication of UA115168U publication Critical patent/UA115168U/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Спосіб застосування кісткового матриксу, отриманого під час резекції головки стегнової кістки при ендопротезуванні шляхом термічної стерилізації з кріопротектором з повідоном, який перед використанням обробляють біотехнологічними продуктами пацієнта, якому його імплантують. Як біотехнологічні продукти використовують жирову тканину, яку промивають у фосфатному буфері, виконують аспірацію буфера, жирову тканину розчиняють у 0,1 % розчині колагенази в шейкері при температурі 37 градусів, зрілі адипоцити та сполучну тканину відділяють від стромальної васкулярної фракції (SVF) шляхом центрифугування при 800 об./хв. протягом 10 хв., для видалення еритроцитів отримані клітини ресуспендують у лізуючому буфері (155 мM NHCl, 10 мМ KНСО, 0,1 мМ EDTA) протягом 5 хв. при кімнатній температурі, клітини промивають у фосфатному буфері та центрифугують при 800 об./хв. протягом 10 хвилин, за показаннями обробляють або поєднують матрикс з цим препаратом.Method of using bone matrix obtained during resection of femoral head during endoprosthesis by thermal sterilization with cryoprotectant with povidone, which is treated with biotechnological products of the patient to whom it is implanted before use. As biotechnological products use adipose tissue washed in phosphate buffer, aspirate buffer, adipose tissue dissolved in 0.1% collagenase solution in a shaker at 37 degrees, mature adipocytes and connective tissue separated from stromal vascular fracture 800 rpm for 10 min, to remove red blood cells, the resulting cells were resuspended in lysis buffer (155 mm NHCl, 10 mm KHSO, 0.1 mm EDTA) for 5 min. at room temperature, the cells were washed in phosphate buffer and centrifuged at 800 rpm. within 10 minutes, the testimony is treated or combined matrix with this drug.

UAU201609191U 2016-09-02 2016-09-02 METHOD OF APPLICATION OF BONE MATRIX UA115168U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201609191U UA115168U (en) 2016-09-02 2016-09-02 METHOD OF APPLICATION OF BONE MATRIX

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201609191U UA115168U (en) 2016-09-02 2016-09-02 METHOD OF APPLICATION OF BONE MATRIX

Publications (1)

Publication Number Publication Date
UA115168U true UA115168U (en) 2017-04-10

Family

ID=58530941

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201609191U UA115168U (en) 2016-09-02 2016-09-02 METHOD OF APPLICATION OF BONE MATRIX

Country Status (1)

Country Link
UA (1) UA115168U (en)

Similar Documents

Publication Publication Date Title
Gómez-Barrena et al. Bone fracture healing: cell therapy in delayed unions and nonunions
Cankaya et al. Cemented calcar replacement versus cementless hemiarthroplasty for unstable intertrochanteric femur fractures in elderly.
DE602005019064D1 (en) PROCESS FOR PREPARING FREEZERTED BLOOD PLATES, FLUIDIZED BLOOD PLATES, COMPOSITIONS AND USE METHOD
JP2015529687A5 (en)
WO2012071526A3 (en) Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
BR112013025048A2 (en) fracture fixation systems having intramedullary support
GB2562406A (en) A method of non destructive monitoring of biological processes in microfluidic tissue culture systems
RU2017120359A (en) INDUCTION OF OSTEOGENESIS BY INTRODUCING RNA CODING BONE MORPHOGENETIC PROTEIN (KMB)
WO2008096268A3 (en) Autologous lymph node transfer in combination with vegf-c or vegf-d growth factor therapy to treat secondary lymphedema and to improve reconstructive surgery
EP4364799A3 (en) Mesenchymal stem cell-derived extracellular vesicles and their medical use
JP2016531923A5 (en)
WO2015159308A3 (en) Osteoinductive formulation and preparation thereof
UA115168U (en) METHOD OF APPLICATION OF BONE MATRIX
JP2015000208A (en) Fracture part treatment member
RU2016137291A (en) IMPLANT CONTAINING FGF-18
Gupta et al. A novel point-of-care in vivo technique for preparation of epidermal cell suspension for transplantation in vitiligo
TW201614066A (en) Composition for treatment of joint disease and method thereof
Sun et al. A new hypothesis on the mechanism of atrophic non-union
UA115170U (en) METHOD OF APPLICATION OF BONE MATRIX
UA115167U (en) METHOD OF APPLICATION OF BONE MATRIX
Maiborodin et al. Risk of thromboembolism after intraosseous implantation of metallic devices with extracellular vesicles derived from multipotent stromal cells: preliminary results
RU2018106008A (en) A method for the surgical treatment of late radiation injuries of soft tissues
Georgiev-Hristov et al. Adipose tissue-derived products for complex fistula treatment
Kumar et al. It should not be here! A strange case of pulmonary cement embolism following balloon kyphoplasty
RU2011117861A (en) METHOD OF OSSICULOPLASTY